Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: The results of a double‐blind, placebo‐controlled challenge study
Open Access
Abstract
Background: Patients with mastocytosis are at increased risk of anaphylaxis. The use of nonsteroidal anti‐inflammatory drugs (NSAIDs) is often discouraged because of this reason. However, the actual prevalence and severity of NSAID‐related hypersensitivity among patients with mastocytosis is unknown.Methods: A double‐blind, placebo‐controlled acetylsalicylic acid (ASA) challenge up to a cumulative dose of 520 mg was performed among adult patients with mastocytosis. In addition, a retrospective search of the entire outpatient cohort was performed to obtain “real‐life” data on NSAID hypersensitivity.Results: Fifty patients underwent an ASA challenge. Seventy percent had indolent systemic mastocytosis, 18% had mastocytosis in the skin, and 12% had advanced mastocytosis. The ASA challenge was positive in 1 patient who developed urticaria. The additional retrospective chart review revealed that 8 of 191 patients had a history of NSAID‐related hypersensitivity reaction(s), of whom 3 reported severe systemic reactions. All 8 patients had already experienced NSAID‐related hypersensitivity reactions before mastocytosis was diagnosed.Conclusions: The frequency of ASA hypersensitivity was 2% in a prospective challenge study and 4.1% in a retrospective chart review of 191 patients with mastocytosis. NSAIDs can be administered safely to most patients with mastocytosis. Extra caution should be taken in patients with a history of hypersensitivity reactions to other drugs, or traditional risk factors for NSAID hypersensitivity.Keywords
This publication has 27 references indexed in Scilit:
- Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centreEuropean Journal of Internal Medicine, 2016
- Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paperAllergy, 2015
- Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase?Allergy, Asthma & Clinical Immunology, 2014
- Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SMJournal of Allergy and Clinical Immunology, 2014
- Adult mastocytosis: a review of the Santo António Hospital 's experience and an evaluation of World Health Organization criteria for the diagnosis of systemic diseaseAnais Brasileiros de Dermatologia, 2014
- High prevalence of anaphylaxis in patients with systemic mastocytosis – a single‐centre experienceClinical & Experimental Allergy, 2013
- Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti‐inflammatory drugsAllergy, 2013
- Case Report: Perioperative immediate hypersensitivity involves not only allergy but also mastocytosisCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2011
- Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D2 ProductionInternational Archives of Allergy and Immunology, 2008
- Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)Clinical & Experimental Allergy, 2007